2m 2m 2m 2m 2m 2m 2m
BIOVENTUS-A (BVS)
NASDAQ
$11.05-$0.13 (-1.16%)
Price as of Nov 11, 2026 7:40 PM EST- $765.5MMarket Cap
- 45.19%1-Year Change
- Medical DevicesIndustry
BIOVENTUS-A (BVS)
$11.05-$0.13 (-1.16%)
BVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.18 | ||
Change | +$0.16 (+1.50%) | ||
Open | $10.95 | ||
High | $11.27 | ||
Low | $10.73 | ||
Previous Close | $11.02 | ||
Volume | 616,243 | ||
30-Day Average Volume | 623,385 | ||
1-Week Change | 2.15% | ||
1-Month Change | -14.43% | ||
1-Year Change | 45.19% | ||
3-Year Change | 217.61% | ||
5-Year Change | -32.24% | ||
Fundamentals | |||
Shares Outstanding | 68.5M | ||
Total Assets | $673.4M | ||
Market Cap | $765.5M | ||
Enterprise Value | $964.7M | ||
Period: QTR TTM FY | |||
Revenue | $142.4M | ||
Net Income | $6.0M | ||
Free Cash Flow | $20.3M | ||
EBIT | $9.0M | ||
EBITDA | $19.4M | ||
Net Working Capital | $107.8M | ||
EPS | $0.08 | ||
Enterprise Value/EBITDA | 50 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 3 | ||
P/E | 140 | ||
PEG | -2 | ||
Price/Free Cash Flow | 38 | ||
Price/Operating Cash Flow | 37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 03/26/2004 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue